A Study on the Anticarcinogenic Effects of Calcium Fructoborate
No Thumbnail Available
Date
2017
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Evidences about the preventive and therapeutic effects of boron compounds on cancer have been increasing in the last years. Although calcium fructoborate (CaFB) is used as a nutritional supplement, data about its preventive and therapeutic effects on neoplastic transformations are limited. In the present study, the various concentrations of CaFB were applied to the MDA-MB-231 metastatic breast cancer cell line. First, we examined the cytotoxic effect and IC50 value of CaFB by MTT assay. For the evaluation of the DNA damage, apoptosis and metastatic potential, expression levels of ATM, pATM, PARP, p53, p-p53, caspase-3, caspase-9, and VEGF were investigated by using immunoblotting and immunohistochemical methods. Cell viability was significantly reduced at 50 μM CaFB treatment. pATM, p-p53, and caspase-9 levels increased significantly in all groups; furthermore, there was approximately 12.5-, 2.4-, and 10.7-fold increase, respectively, for 100 μM CaFB treatment. ATM and p53 levels did not change with CaFB treatment, but PARP levels significantly 2.5-fold decreased. While VEGF immunoreactivity decreased in all groups, significant increase in caspase-3 immunoreactivity was observed only in the group treated with 50 μM CaFB (p < 0,001). Our results imply that CaFB may have therapeutic potential as well as preventive benefits in cancer. © 2016, Springer Science+Business Media New York.
Description
Keywords
Anticarcinogenic Agents , Borates , Breast Neoplasms , Cell Line, Tumor , Drug Screening Assays, Antitumor , Female , Fructose , Humans , Neoplasm Proteins , ATM protein , boric acid , calcium fructoborate , caspase 3 , caspase 9 , DNA , nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase , nutrition supplement , protein p53 , unclassified drug , vasculotropin , antineoplastic agent , boric acid , calcium fructoborate , fructose , tumor protein , apoptosis , Article , cell viability , controlled study , cytotoxicity , DNA damage , female , human , IC50 , immunoblotting , immunohistochemistry , immunoreactivity , MDA-MB-231 cell line , metastatic breast cancer , MTT assay , protein expression , analogs and derivatives , breast tumor , drug screening , metabolism , pathology , tumor cell line